NewsRx

Search our medical news database

LifePoint Hospitals, Inc.

Hospital corporation sets pricing of $200 million of subordinated debentures

Published in Hospital and Nursing Home Week, September 8th, 2005

LifePoint Hospitals, Inc. (LPNT) announced the pricing of $200 million in aggregate principal amount of its convertible senior subordinated debentures due 2025.

In addition, the company granted the initial purchasers an option to purchase up to an additional $25 million in aggregate principal amount of the debentures solely to cover overallotments.

The debentures will bear regular interest at the annual rate of 3.25%. The debentures may be converted, under certain circumstances, into a combination of cash and common stock of the company. The conversion rate initially will be approximately 16.3345 shares of common stock per $1,000 principal amount of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook